FDA - Spark Newswire

5 minute read

FDA
News

Establishment Labs Highlights Publication Of Breast Implant Surface Research In Nature Biomedical Engineering

Today, 12:37 PM

Professor Robert Langer and a team of MIT scientists demonstrated that an optimal breast implant surface architecture leads to significantly lower levels of inflammatory foreign body response and to healthier tissue

ESTA

1 minute read

Albireo’s Bylvay Shows Further Evidence Of Sustained, Durable Effect In Pediatric Liver Disease Study

By Vandana Singh

Today, 12:37 PM

Albireo Pharma Inc (NASDAQ:ALBO) has announced pooled analysis from Phase 3 PEDFIC studies with Bylvay (odevixibat) and advancement in the characterization…

ALBO

1 minute read

Anavex Life’s Rett Syndrome Candidate Shows Promising Biomarker Correlating Efficacy Data

By Vandana Singh

Today, 12:37 PM

Anavex Life Sciences Corp (NASDAQ:AVXL) has reported a predictive biomarker response from its Phase 2 trial of ANAVEX2-73 (blarcamesine) in…

AVXL

6 minute read

FDA
News

Medtronic Sayts Receives FDA Expanded Approval for Arctic Front Family Of Cardiac Cryoablation Catheters For Initial Use For Recurrent Symptomatic Paroxysmal Atrial Fibrillation

By Benzinga Newsdesk

Today, 12:37 PM

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it received U.S. Food and Drug Administration (FDA) expanded approval for the Arctic Front™ Family of Cardiac Cryoablation

MDT

1 minute read

McKesson Says TRUSELTIQ Available At Biologics By McKesson

By Benzinga Newsdesk

Today, 12:37 PM

https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2021/TRUSELTIQ-FDA-Approved-for-Treatment-of-Cholangiocarcinoma/

MCK

1 minute read

Prometheus Biosciences Says Achieves Milestone Payment Of $10M From Dr. Falk Pharma GmbH

By Benzinga Newsdesk

Today, 12:37 PM

Prometheus Biosciences, Inc. (NASDAQ:RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion

RXDX

3 minute read

FDA
News

Moleculin Biotech Reports First Subject Enrolled, Dosed In Phase 1b/2 Trial Of Annamycin For Treatment Of Sarcoma Lung Metastases

By Benzinga Newsdesk

Today, 12:37 PM

- Annamycin granted Fast Track Status and Orphan Drug Designation from FDA for the treatment of soft tissue sarcoma lung metastases - Interim data expected in the second half of 2022 HOUSTON, June 21, 2021 /PRNewswire/

MBRX

6 minute read

FDA
News

Aligos Therapeutics To Present Phase 1 Safety, Pharmacokinetic Data for STOPS Molecule Drug Candidate ALG-010133 And Several Nonclinical Chronic Hepatitis B Programs At Digital International Liver Congress 2021

By Benzinga Newsdesk

Today, 12:37 PM

Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that a poster

ALGS

1 minute read

FDA
News

Eli Lilly Canada Reports Health Canada Issued Notice Of Compliance With Conditions For Retevmo

By Benzinga Newsdesk

Today, 12:37 PM

-Reuters

LLY

2 minute read

FDA
News

Virpax To Use Envelta IND Enabling Study Results For 2 Additional Indications

By Benzinga Newsdesk

Today, 12:37 PM

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being

VRPX